Nov 16 (Reuters) - Futures tracking the S&P 500 and the Dow
rose on Monday after Moderna Inc MRNA.O said its experimental
vaccine was 94.5% effective in preventing COVID-19, a week after
Pfizer Inc PFE.N reported positive results from its own
late-stage trial.
At 7:00 a.m. ET, Dow e-minis 1YMcv1 were up 488 points, or
1.66%, and S&P 500 e-minis EScv1 were up 39.5 points, or 1.1%.
Nasdaq 100 e-minis NQcv1 erased early gains to trade down 5.5
points, or 0.05%.